Silvercrest Asset Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-267,604
Closed -$7.5M 828
2024
Q3
$7.5M Sell
267,604
-1,540
-0.6% -$38K 0.05% 314
2024
Q2
$6.13M Buy
269,144
+78,594
+41% +$1.81M 0.04% 364
2024
Q1
$5.8M Sell
190,550
-67,315
-26% -$2.25M 0.04% 365
2023
Q4
$9.2M Buy
257,865
+55,115
+27% +$2.05M 0.07% 254
2023
Q3
$8.88M Sell
202,750
-48,636
-19% -$2.37M 0.07% 249
2023
Q2
$12.4M Buy
251,386
+37,506
+18% +$1.73M 0.09% 213
2023
Q1
$8.87M Sell
213,880
-184
-0.1% -$7.63K 0.07% 247
2022
Q4
$9.5M Sell
214,064
-3,266
-2% -$136K 0.07% 227
2022
Q3
$8.5M Sell
217,330
-5,388
-2% -$246K 0.07% 241
2022
Q2
$9.1M Buy
222,718
+72,191
+48% +$3.42M 0.07% 243
2022
Q1
$9.88M Buy
150,527
+1,773
+1% +$115K 0.06% 259
2021
Q4
$10.3M Buy
148,754
+755
+0.5% +$54.9K 0.07% 256
2021
Q3
$10.3M Sell
147,999
-3,281
-2% -$252K 0.07% 260
2021
Q2
$12M Sell
151,280
-44,050
-23% -$3.2M 0.08% 244
2021
Q1
$12.8M Sell
195,330
-26,402
-12% -$1.63M 0.09% 237
2020
Q4
$12.3M Buy
221,732
+6,067
+3% +$262K 0.09% 222
2020
Q3
$8.61M Buy
215,665
+44,720
+26% +$1.9M 0.07% 244
2020
Q2
$7.68M Sell
170,945
-44,831
-21% -$1.95M 0.07% 243
2020
Q1
$7.25M Sell
215,776
-38,193
-15% -$1.37M 0.08% 225
2019
Q4
$8.26M Sell
253,969
-66,743
-21% -$1.9M 0.06% 251
2019
Q3
$8M Buy
+320,712
New +$9.16M 0.07% 241

Other funds holding ATRC

Silvercrest Asset Management's ATRC Position: Q4 2024 in Review

Silvercrest Asset Management sold out of AtriCure (ATRC) in Q4 2024, closing a stake of 267,604 shares — an estimated $7.5M sold.

Silvercrest Asset Management first reported a position in ATRC in Q3 2019 and held it in 21 quarters. The position peaked at $12.8M in Q1 2021. 213 funds tracked by Wall St. Rank hold ATRC as of Q4 2024.

  • Silvercrest Asset Management reported no remaining AtriCure position as of Q4 2024 after selling out during the quarter.
  • Silvercrest Asset Management sold 267,604 AtriCure shares in Q4 2024, an estimated $7.5M.
  • Silvercrest Asset Management first reported a position in AtriCure in Q3 2019 and held it in 21 quarters.
  • Silvercrest Asset Management's AtriCure position peaked at $12.8M in Q1 2021.
  • 213 funds tracked by Wall St. Rank held AtriCure as of Q4 2024.

Based on Silvercrest Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.